NCT06585982View on ClinicalTrials.gov

Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

March 7, 2025

Study Completion Date

March 7, 2025

Conditions
Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Treatment

RILLUS is a synbiotic produced by Kalbe Farma

DIETARY_SUPPLEMENT

Control

Placebo produced by Kalbe Farma

Trial Locations (1)

50244

RECRUITING

RSUP Dr. Kariadi, Semarang

All Listed Sponsors
collaborator

Dr. Kariadi General Hospital Medical Center

OTHER

collaborator

PT Kalbe Farma Tbk

INDUSTRY

lead

Universitas Diponegoro

OTHER